Literature DB >> 15505121

Postprandial glucose regulation and diabetic complications.

Antonio Ceriello1, Markolf Hanefeld, Lawrence Leiter, Louis Monnier, Alan Moses, David Owens, Naoko Tajima, Jaakko Tuomilehto.   

Abstract

Atherosclerotic disease accounts for much of the increased mortality and morbidity associated with type 2 diabetes. Epidemiological studies support the potential of improved glycemic control to reduce cardiovascular complications. An association between glycosylated hemoglobin (HbA(1c)) level and the risk for cardiovascular complications has frequently been reported. Most epidemiological data implicate postprandial hyperglycemia in the development of cardiovascular disease, whereas the link between fasting glycemia and diabetic complications is inconclusive. Moreover, in many studies, postprandial glycemia is a better predictor of cardiovascular risk than HbA(1c) level. Postprandial glucose may have a direct toxic effect on the vascular endothelium, mediated by oxidative stress that is independent of other cardiovascular risk factors such as hyperlipidemia. Postprandial hyperglycemia also may exert its effects through its substantial contribution to total glycemic exposure. The present review examines the hypothesis that controlling postprandial glucose level is an important strategy in the prevention of cardiovascular complications associated with diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505121     DOI: 10.1001/archinte.164.19.2090

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  100 in total

1.  Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet.

Authors:  Belinda S Lennerz; Anna Barton; Richard K Bernstein; R David Dikeman; Carrie Diulus; Sarah Hallberg; Erinn T Rhodes; Cara B Ebbeling; Eric C Westman; William S Yancy; David S Ludwig
Journal:  Pediatrics       Date:  2018-05-07       Impact factor: 7.124

2.  To: Strey CH, Young J, Collier M, Florkowski CM, Shand BI, Scott RS (2004) The postprandial state does not impair endothelial function in women with Type 2 diabetes irrespective of glycaemic control. Diabetologia 47:1838-1846.

Authors:  A Ceriello; M Hanefeld; L Leiter; L Monnier; D Owens; N Tajima; J Tuomilehto
Journal:  Diabetologia       Date:  2005-06-10       Impact factor: 10.122

3.  Real-time continuous glucose monitoring in the clinical setting: the good, the bad, and the practical.

Authors:  Irene Mamkin; Svetlana Ten; Sonal Bhandari; Neesha Ramchandani
Journal:  J Diabetes Sci Technol       Date:  2008-09

4.  A New Animal Model of Insulin-Glucose Dynamics in the Intraperitoneal Space Enhances Closed-Loop Control Performance.

Authors:  Ankush Chakrabarty; Justin M Gregory; L Merkle Moore; Philip E Williams; Ben Farmer; Alan D Cherrington; Peter Lord; Brian Shelton; Don Cohen; Howard C Zisser; Francis J Doyle; Eyal Dassau
Journal:  J Process Control       Date:  2019-02-23       Impact factor: 3.666

5.  A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study.

Authors:  Weiwei Zhang; Dongjun Kim; Elizabeth Philip; Zahid Miyan; Irina Barykina; Birgit Schmidt; Herbert Stein
Journal:  Clin Drug Investig       Date:  2013-04       Impact factor: 2.859

6.  Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease.

Authors:  Kenneth S Hershon; Barbara R Hirsch; Ola Odugbesan
Journal:  Clin Diabetes       Date:  2019-07

7.  The Effect of Glucose Fluctuation on Apoptosis and Function of INS-1 Pancreatic Beta Cells.

Authors:  Mi Kyung Kim; Hye Sook Jung; Chang Shin Yoon; Jung Hae Ko; Hae Jung Jun; Tae Kyun Kim; Min Jeong Kwon; Soon Hee Lee; Kyung Soo Ko; Byoung Doo Rhee; Jeong Hyun Park
Journal:  Korean Diabetes J       Date:  2010-02-28

8.  Counterpoint: postprandial glucose levels are not a clinically important treatment target.

Authors:  Mayer B Davidson
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 19.112

9.  Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia.

Authors:  J C Brand-Miller; F S Atkinson; R J Gahler; V Kacinik; M R Lyon; S Wood
Journal:  Eur J Clin Nutr       Date:  2010-10-06       Impact factor: 4.016

10.  Incretin-based therapies: new treatments for type 2 diabetes in the new millennium.

Authors:  Joan Khoo; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Ther Clin Risk Manag       Date:  2009-08-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.